Q32 Bio Inc. Cash and Cash Equivalents
Q32 Bio Inc. (QTTB) had Cash and Cash Equivalents of $106.27 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-05
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $106.27M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $50.75M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $48.30M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $49.04M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $106.27M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $50.75M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $48.30M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $49.04M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $54.83M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $65.48M 10-Q · filed 2026-05-05 | |
| 2024-12-31 | $77.97M 10-K · filed 2026-03-10 | |
| 2024-09-30 | $89.08M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $97.66M 10-Q · filed 2025-08-06 | |
| 2024-03-31 | $115.51M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $25.62M 10-K · filed 2025-03-11 | $39.27M 10-K · filed 2024-03-13 |
| 2023-09-30 | $36.26M 10-Q · filed 2024-11-07 | $29.11M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $20.06M 10-Q · filed 2024-08-08 | $76.80M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $31.41M 10-Q · filed 2024-05-09 | $39.45M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $33.99M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $43.16M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $176.19M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $248.13M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $108.38M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $95.83M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $116.31M 10-Q · filed 2022-08-15 | |
| 2021-03-31 | $104.42M 10-Q · filed 2022-05-16 | |
| 2020-12-31 | $217.43M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $178.00M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $167.64M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $143.37M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $53.77M 10-K · filed 2021-03-11 | |
| 2019-09-30 | $77.56M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $115.57M 10-Q · filed 2020-08-10 | |
| 2019-03-31 | $40.84M 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $38.22M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $36.04M 10-Q · filed 2019-11-12 | $36.04M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $94.96M 10-Q · filed 2019-08-08 | $94.96M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $46.21M 10-Q · filed 2019-05-13 | $46.21M 10-Q · filed 2018-05-14 |
| 2017-12-31 | $51.58M 10-K · filed 2019-03-12 | $51.57M 10-Q · filed 2018-05-14 |
| 2017-09-30 | $97.77M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $20.43M 10-Q · filed 2018-08-13 | |
| 2017-03-31 | $26.50M 10-Q · filed 2018-05-14 | |
| 2016-12-31 | $11.39M 10-K · filed 2019-03-12 | $11.39M 10-Q · filed 2018-05-14 |